Novo Nordisk Patient Assistance Program (PAP) Drug manufacturing companies, such as Novo Nordisk, offer patient assistance programs (PAPs) to help patients who cannot afford their medications
Cardiovasc Res 36:276281 Masaki I, Yonemitsu Y, Yamashita A, Sata S, Tanii M, Komori K, Nakagawa K, Hou X, Nagai Y, Hasegawa M et al (2002) Angiogenic gene therapy for experimental critical limb ischemia: acceleration of limb loss by overexpression of vascular endothelial growth factor 165 but not of fibroblast growth factor-2
4 Zeisel SH, da Costa KA Choline: an essential nutrient for public health (Nutr Rev, 2009)Review establishing that choline deficiency causes hepatic fat accumulation and liver injury, and that repletion reverses deficiency-related steatosis
L., Sadiku, R
10 FDA Compounded and Unapproved DrugsFDA guidance on compounded/unapproved drug products and their regulatory status